Llwytho...
Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D
BACKGROUND: Clinical guidelines recommend that women with hormone-receptor positive breast cancer receive endocrine therapy (selective estrogen receptor modulators [SERMs] or aromatase inhibitors [AIs]) for five years following diagnosis. OBJECTIVE: To examine utilization and adherence to therapy fo...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Centers for Medicare & Medicaid Services
2011
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4010443/ https://ncbi.nlm.nih.gov/pubmed/22340780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5600/mmrr.001.04.a04 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|